Health
Women in Wales turn to online pharmacies for testosterone amid NHS prescription disparities
Difficulties accessing off-license hormone treatments through primary care have led some women to misrepresent their identity online, risking severe side effects from uncontrolled dosages.
The short version
- Some post-menopausal women in Wales are posing as men on online pharmacy platforms to obtain testosterone due to regional inconsistencies in NHS prescribing.
- Medical specialists report treating women with hormone levels up to 12 times above safe limits, which carries risks of irreversible side effects like voice deepening and hair loss.
- Prescription policies vary significantly across the seven Welsh health boards because there is currently no NHS-funded testosterone treatment specifically licensed for women.
- A female-targeted product, Androfeme, holds a UK license but awaits a cost-effectiveness appraisal by NICE before potential NHS adoption.
Key facts
- Specialists report that women in Wales are falsifying information on online pharmacy questionnaires to buy testosterone after facing barriers to NHS prescriptions.[BBC News]
- Unmonitored online purchasing has resulted in patients presenting with testosterone concentrations up to 12 times the safe physiological range, risking permanent side effects such as balding, voice changes, and clitoral enlargement.[BBC News]
- The NHS currently lacks a funded female-specific testosterone product, requiring doctors to prescribe lower, off-license doses of products formulated for men.[BBC News]
- Prescribing guidelines differ widely across the seven Welsh health boards, leading some GP practices to restrict or ban testosterone prescriptions and redirect patients to hospital gynaecology waiting lists.[BBC News]
- While the female testosterone product Androfeme has obtained a UK licence, it must undergo a NICE appraisal to assess cost-effectiveness before NHS availability.[BBC News]
- The Welsh government stated that health boards are expected to offer individualized care under NICE menopause guidelines and adhere to upcoming recommendations on testosterone.[BBC News]
What remains uncertain
- Whether NICE will recommend NHS funding for the licensed female product Androfeme following its cost-effectiveness appraisal, given its roughly £100 cost compared to £30 for male alternatives.[BBC News]
- The scientific validity of anecdotal reports that testosterone improves cognition and energy in women, which remains under investigation in an ongoing Welsh study.[BBC News]